Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124696935 | 12469693 | 5 | F | 20160815 | 20160615 | 20160818 | PER | US-ACTELION-A-US2016-137044 | ACTELION | 66.00 | YR | E | F | Y | 0.00000 | 20160818 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124696935 | 12469693 | 1 | PS | UPTRAVI | SELEXIPAG | 1 | Oral | 400 MCG, BID | U | U | 207947 | 400 | UG | TABLET | BID | ||||
| 124696935 | 12469693 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 150022A,1504768A,1509427A | 0 | 10 | MG | QD | ||||||
| 124696935 | 12469693 | 3 | SS | ADCIRCA | TADALAFIL | 1 | Oral | U | U | 0 | |||||||||
| 124696935 | 12469693 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 5 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 6 | C | THYROID | LEVOTHYROXINELIOTHYRONINE | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 7 | C | LUTEIN | LUTEIN | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 10 | C | PREDNISONE. | PREDNISONE | 1 | U | 0 | |||||||||||
| 124696935 | 12469693 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124696935 | 12469693 | 1 | Pulmonary arterial hypertension |
| 124696935 | 12469693 | 2 | Pulmonary arterial hypertension |
| 124696935 | 12469693 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124696935 | 12469693 | Arthralgia | |
| 124696935 | 12469693 | Decreased appetite | |
| 124696935 | 12469693 | Diarrhoea | |
| 124696935 | 12469693 | Fatigue | |
| 124696935 | 12469693 | Headache | |
| 124696935 | 12469693 | Nausea | |
| 124696935 | 12469693 | Oxygen saturation decreased | |
| 124696935 | 12469693 | Poor quality sleep | |
| 124696935 | 12469693 | Rash | |
| 124696935 | 12469693 | Visual impairment | |
| 124696935 | 12469693 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124696935 | 12469693 | 2 | 20160113 | 0 |